Stay updated on Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Sign up to get notified when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a small update to the page or its metadata rather than a change to the study details. It does not alter the information presented about the trial.
    Difference
    0.1%
    Check dated 2026-08-29T21:55:23.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.6.5, replacing v3.6.4. This is a minor software version update and does not change study content or page functionality.
    Difference
    0.1%
    Check dated 2026-08-08T23:14:51.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Revision marker updated to v3.6.4 on the page footer, indicating a new deployment. The study content and data remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-25T16:59:58.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page footer shows Revision: v3.6.3, replacing v3.6.2, indicating a small maintenance update to the site.
    Difference
    0.1%
    Check dated 2026-07-04T04:50:17.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a platform/template update that affects the page wrapper rather than study information.
    Difference
    0.1%
    Check dated 2026-06-27T02:55:08.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    The study page now indicates that it is no longer recruiting participants, signaling that enrollment is closed. New navigation and guidance sections such as How to Read a Study Record, Common Questions, How to Join a Study, and an Intervention/Treatment heading were added, reflecting a reorganization and improved user guidance.
    Difference
    0.5%
    Check dated 2026-06-12T16:31:11.000Z thumbnail image

Stay in the know with updates to Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sustained Release Dalfampridine in Transverse Myelitis Clinical Trial page.